Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Ronacaleret

Generic Name: Ronacaleret

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₃₁F_₂NO_₄

CAS Number: 753449-67-1

Unique Ingredient Identifier: DIH95YP7J3

Overview

Ronacaleret is a calcium-sensing receptor antagonist.

Background

Ronacaleret is a calcium-sensing receptor antagonist.

Indication

Post-menopausal women with osteoporosis

Associated Conditions

No associated conditions information available.

Clinical Trials

Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret)

Phase 1

Completed

Posted: 2013/03/04

Sponsor:GlaxoSmithKline

ID:NCT01802892

An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers

Phase 1

Completed

Posted: 2011/11/06

Sponsor:GlaxoSmithKline

ID:NCT01466335

To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females

Phase 1

Completed

Posted: 2008/04/02

Sponsor:GlaxoSmithKline

ID:NCT00651534

A Study of SB751689 in Japanese Postmenopausal Women

Phase 1

Completed

Posted: 2007/11/06

Sponsor:GlaxoSmithKline

ID:NCT00554255

A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius

Phase 2

Terminated

Posted: 2007/10/24

Sponsor:GlaxoSmithKline

ID:NCT00548496

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy